Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of May 30 to June 3, 2016.
GI & Endoscopy
EndoChoice stock declined 6.36 percent in short interest, according to a Wall Street Hints & News report.
Gastroenterology Associates added four new providers to its St. Vincent's East office in Birmingham.
A study presented at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago found an antibody-based experimental therapy is lengthening the life-span of patients suffering from stomach cancer, Tucson.com reports.
Anthony N. Kalloo, MD, MBBS, is the chief of the gastroenterology and hepatology division at Johns Hopkins Hospital in Baltimore.
Here are six gastroenterologists who recently made headlines.
Robert W. Beart, MD, recently received honors from Dignity Health Glendale (Calif.) Memorial Hospital and the American Society of Colon and Rectal Surgeons.
The European Commission approved the Swiss-based Novartis drug Afinitor for advanced gastrointestinal and lung neuroendocrine tumor treatment.
David A. Piccoli, MD, is the chief of the gastroenterology, hepatology and nutrition division at Children's Hospital of Philadelphia. He is also the director of the Fred and Suzanne Biesecker Pediatric Liver Center at CHOP.
Stretta found to be effective in more GERD patient sub-sets: Q&A with Dr. Mark Noar on his follow-up to 10-year patient data.
